Pediatric basal cell carcinoma: case reports and literature review

Philip A Efron1, Mike K Chen, Frederick L Glavin

  • 1Division of Pediatric Surgery, University of Florida College of Medicine, Box 100286, Gainesville, FL 32610, USA.

Insights

Pediatric basal cell carcinoma (BCC) is rare and often missed, delaying treatment. Increased caregiver awareness of childhood BCC can speed diagnosis and genetic syndrome evaluation.

Area of Science:

  • Dermatology
  • Pediatric Oncology
  • Genetics

Background:

  • Basal cell carcinoma (BCC) is uncommon in children, often associated with genetic syndromes.
  • Diagnosis is typically confirmed by biopsy, but physician suspicion can be low in pediatric cases.
  • Delayed diagnosis can impede timely treatment and necessary genetic evaluations.

Observation:

  • This study presents three pediatric cases of basal cell carcinoma.
  • A literature review on childhood BCC was conducted.
  • Cases highlight the challenges in diagnosing BCC in young patients.

Findings:

  • Pediatric BCC often occurs in children with underlying genetic conditions.
  • Low physician suspicion can lead to delayed diagnosis and treatment.
  • Early recognition of BCC in children is crucial.

Implications:

  • Increased awareness among pediatric healthcare providers can expedite BCC diagnosis and treatment.
  • Prompt diagnosis facilitates evaluation for associated genetic syndromes.
  • Improved knowledge of pediatric BCC can enhance patient outcomes and management.